vs
Side-by-side financial comparison of Armour Residential REIT, Inc. (ARR) and Inogen Inc (INGN). Click either name above to swap in a different company.
Inogen Inc is the larger business by last-quarter revenue ($68.6M vs $50.4M, roughly 1.4× Armour Residential REIT, Inc.). On growth, Armour Residential REIT, Inc. posted the faster year-over-year revenue change (297.9% vs 3.4%). Over the past eight quarters, Armour Residential REIT, Inc.'s revenue compounded faster (108.0% CAGR vs 4.2%).
Armour Residential REIT, Inc. is a U.S.-based real estate investment trust that primarily invests in agency residential mortgage-backed securities guaranteed by U.S. government-sponsored entities. It focuses on generating consistent long-term net income for shareholders via strategic asset management and active interest rate risk mitigation.
Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.
ARR vs INGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $50.4M | $68.6M |
| Net Profit | $211.7M | — |
| Gross Margin | — | 51.4% |
| Operating Margin | — | -13.6% |
| Net Margin | 420.2% | — |
| Revenue YoY | 297.9% | 3.4% |
| Net Profit YoY | 555.9% | — |
| EPS (diluted) | $2.43 | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $50.4M | $68.6M | ||
| Q3 25 | $38.5M | $79.1M | ||
| Q2 25 | $33.1M | $79.2M | ||
| Q1 25 | $36.3M | $68.5M | ||
| Q4 24 | $12.7M | $66.3M | ||
| Q3 24 | — | $74.9M | ||
| Q2 24 | $7.0M | $74.4M | ||
| Q1 24 | — | $63.1M |
| Q4 25 | $211.7M | — | ||
| Q3 25 | $159.3M | $-5.3M | ||
| Q2 25 | $-75.6M | $-4.2M | ||
| Q1 25 | $27.3M | $-6.2M | ||
| Q4 24 | $-46.4M | — | ||
| Q3 24 | — | $-6.0M | ||
| Q2 24 | $-48.4M | $-5.6M | ||
| Q1 24 | — | $-14.6M |
| Q4 25 | — | 51.4% | ||
| Q3 25 | — | 52.2% | ||
| Q2 25 | — | 52.2% | ||
| Q1 25 | — | 53.1% | ||
| Q4 24 | — | 54.7% | ||
| Q3 24 | — | 55.2% | ||
| Q2 24 | — | 57.4% | ||
| Q1 24 | — | 54.5% |
| Q4 25 | — | -13.6% | ||
| Q3 25 | — | -9.0% | ||
| Q2 25 | — | -7.7% | ||
| Q1 25 | — | -11.2% | ||
| Q4 24 | — | -17.2% | ||
| Q3 24 | — | -10.4% | ||
| Q2 24 | — | -9.5% | ||
| Q1 24 | — | -25.8% |
| Q4 25 | 420.2% | — | ||
| Q3 25 | 413.5% | -6.7% | ||
| Q2 25 | -228.4% | -5.2% | ||
| Q1 25 | 75.2% | -9.0% | ||
| Q4 24 | -366.8% | — | ||
| Q3 24 | — | -8.0% | ||
| Q2 24 | -693.8% | -7.5% | ||
| Q1 24 | — | -23.1% |
| Q4 25 | $2.43 | $-0.26 | ||
| Q3 25 | $1.49 | $-0.20 | ||
| Q2 25 | $-0.94 | $-0.15 | ||
| Q1 25 | $0.32 | $-0.25 | ||
| Q4 24 | $-0.91 | $-0.41 | ||
| Q3 24 | — | $-0.25 | ||
| Q2 24 | $-1.05 | $-0.24 | ||
| Q1 24 | — | $-0.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.3M | $103.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.3B | $192.2M |
| Total Assets | $21.0B | $298.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.3M | $103.7M | ||
| Q3 25 | $44.2M | $106.5M | ||
| Q2 25 | $141.2M | $103.7M | ||
| Q1 25 | $49.1M | $118.9M | ||
| Q4 24 | $68.0M | $113.8M | ||
| Q3 24 | — | $105.7M | ||
| Q2 24 | $126.6M | $97.9M | ||
| Q1 24 | — | $107.4M |
| Q4 25 | $2.3B | $192.2M | ||
| Q3 25 | $2.1B | $197.2M | ||
| Q2 25 | $1.7B | $199.5M | ||
| Q1 25 | $1.7B | $198.0M | ||
| Q4 24 | $1.4B | $173.9M | ||
| Q3 24 | — | $185.4M | ||
| Q2 24 | $1.2B | $187.6M | ||
| Q1 24 | — | $191.9M |
| Q4 25 | $21.0B | $298.6M | ||
| Q3 25 | $19.4B | $307.0M | ||
| Q2 25 | $16.2B | $312.0M | ||
| Q1 25 | $15.5B | $308.4M | ||
| Q4 24 | $13.5B | $296.2M | ||
| Q3 24 | — | $306.2M | ||
| Q2 24 | $10.1B | $308.9M | ||
| Q1 24 | — | $315.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $124.2M | $-943.0K |
| Free Cash FlowOCF − Capex | — | $-1.9M |
| FCF MarginFCF / Revenue | — | -2.8% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | 0.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $124.2M | $-943.0K | ||
| Q3 25 | $-37.8M | $2.2M | ||
| Q2 25 | $25.0M | $4.3M | ||
| Q1 25 | $101.5M | $-16.8M | ||
| Q4 24 | $261.5M | $-3.0M | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | $27.1M | $6.7M | ||
| Q1 24 | — | $-4.7M |
| Q4 25 | — | $-1.9M | ||
| Q3 25 | — | $1.6M | ||
| Q2 25 | — | $3.7M | ||
| Q1 25 | — | $-17.1M | ||
| Q4 24 | — | $-3.3M | ||
| Q3 24 | — | $5.3M | ||
| Q2 24 | — | $6.6M | ||
| Q1 24 | — | $-6.1M |
| Q4 25 | — | -2.8% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | -24.9% | ||
| Q4 24 | — | -5.0% | ||
| Q3 24 | — | 7.1% | ||
| Q2 24 | — | 8.9% | ||
| Q1 24 | — | -9.6% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | 0.59× | — | ||
| Q3 25 | -0.24× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.71× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARR
Segment breakdown not available.
INGN
| Other | $36.1M | 53% |
| Non Us | $32.5M | 47% |
